Exane Derivatives’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-356
| Closed | -$33.1K | – | 1096 |
|
|
2021
Q4 | $33.1K | Sell |
356
-2,072
| -85% | -$193K | 0.01% | 542 |
|
|
2021
Q3 | $145K | Buy |
2,428
+1,052
| +76% | +$62.6K | 0.03% | 458 |
|
|
2021
Q2 | $91.9K | Buy |
+1,376
| New | +$91.9K | 0.02% | 542 |
|
|
2021
Q1 | – | Sell |
-448
| Closed | -$34.4K | – | 970 |
|
|
2020
Q4 | $34.4K | Sell |
448
-87
| -16% | -$6.68K | 0.01% | 473 |
|
|
2020
Q3 | $40K | Hold |
535
| – | – | 0.01% | 367 |
|
|
2020
Q2 | $33.7K | Hold |
535
| – | – | 0.01% | 358 |
|
|
2020
Q1 | $22.5K | Sell |
535
-400
| -43% | -$16.8K | 0.01% | 381 |
|
|
2019
Q4 | $42.2K | Sell |
935
-3,741
| -80% | -$169K | 0.01% | 349 |
|
|
2019
Q3 | $214K | Sell |
4,676
-703
| -13% | -$32.2K | 0.04% | 237 |
|
|
2019
Q2 | $315K | Buy |
+5,379
| New | +$315K | 0.06% | 200 |
|